IPO Profile: Alder Biopharmaceuticals Inc

Investors Delphi Ventures, H.I.G. Capital LLC, Novo A/S and others invested more than $105 million for a total return of 2.43x at the time of the IPO

1 July 2014•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail